Wail Nammas
Overview
Explore the profile of Wail Nammas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
128
Citations
350
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Uurasmaa T, Bourdin P, Nammas W, Latifi S, Liljenback H, Saraste A, et al.
J Transl Med
. 2025 Jan;
23(1):89.
PMID: 39838445
Introduction: Doxorubicin is a chemotherapeutic drug used to treat various cancers. Exercise training (ET) can attenuate some cardiotoxic effects of doxorubicin (DOX) in tumor-free animals. However, the ET effects on...
2.
Maaniitty T, Maenpaa M, Harjulahti E, Kujala I, Stenstrom I, Nammas W, et al.
JACC Cardiovasc Imaging
. 2024 Aug;
18(1):62-73.
PMID: 39207334
Background: Anatomical and functional imaging identify different phenotypes of coronary artery disease (CAD) that may have implications for lipid-lowering medication (LLM). Objectives: The aim of this study was to assess...
3.
Dietz M, Kamani C, Bousige C, Dunet V, Delage J, Rubimbura V, et al.
J Nucl Med
. 2024 May;
65(7):1107-1112.
PMID: 38724280
Angiogenesis is an essential part of the cardiac repair process after myocardial infarction, but its spatiotemporal dynamics remain to be fully deciphered.Ga-NODAGA-Arg-Gly-Asp (RGD) is a PET tracer targeting αβ integrin...
4.
Haddad F, Saraste A, Santalahti K, Pankaala M, Kaisti M, Kandolin R, et al.
JACC Heart Fail
. 2024 Apr;
12(6):1030-1040.
PMID: 38573263
Background: Heart failure (HF) is the leading cause of hospitalization in individuals over 65 years of age. Identifying noninvasive methods to detect HF may address the epidemic of HF. Seismocardiography...
5.
Nammas W, Paunonen C, Teuho J, Siekkinen R, Luoto P, Kakela M, et al.
J Nucl Med
. 2023 Nov;
65(1):132-138.
PMID: 37973184
[Ga]Ga-NODAGA-Arg-Gly-Asp (RGD) is a PET tracer targeting αβ integrin, which is upregulated during angiogenesis soon after acute myocardial infarction (AMI). We prospectively evaluated determinants of myocardial uptake of [Ga]Ga-NODAGA-RGD and...
6.
Nesterov S, Raty J, Nammas W, Maaniitty T, Galloo X, Stassen J, et al.
Eur J Heart Fail
. 2023 Oct;
26(1):117-126.
PMID: 37905338
Aims: We sought to evaluate the mechanism of angiotensin receptor-neprilysin inhibitor (ARNI) sacubitril/valsartan therapy and compare it with a valsartan-only control group in patients with heart failure with reduced ejection...
7.
Maenpaa M, Kujala I, Harjulahti E, Stenstrom I, Nammas W, Knuuti J, et al.
Cardiovasc Diabetol
. 2023 May;
22(1):129.
PMID: 37254111
Background: Patients with prediabetes or diabetes are at increased risk of developing cardiovascular disease and adverse outcomes. First-line coronary computed tomography angiography (CTA) followed by selective use of positron emission...
8.
Kujala I, Nammas W, Maaniitty T, Stenstrom I, Klen R, Bax J, et al.
Eur Heart J Cardiovasc Imaging
. 2023 Apr;
24(9):1201-1209.
PMID: 37086269
Aims: Combined anatomical and functional imaging enables detection of non-obstructive and obstructive coronary artery disease (CAD) as well as myocardial ischaemia. We evaluated sex differences in disease profile and outcomes...
9.
Negi P, Heikkila T, Vuorenpaa K, Tuunainen E, Nammas W, Maaniitty T, et al.
Front Cardiovasc Med
. 2022 Oct;
9:912578.
PMID: 36312264
Objective: High-density lipoprotein (HDL) is a heterogeneous group of subpopulations differing in protein/lipid composition and in their anti-atherogenic function. There is a lack of assays that can target the functionality...
10.
Sia J, Nammas W, Collet C, De Bruyne B, Karjalainen P
Rev Esp Cardiol (Engl Ed)
. 2022 Jun;
76(3):150-156.
PMID: 35752571
Introduction And Objectives: To evaluate by optical coherence tomography neointimal healing response after implantation of cobalt-chromium-based titanium-nitride-oxide-coated (TiNO) stents and platinum-chromium-based biodegradable-polymer-coated everolimus-eluting stents (EES) in patients with acute coronary...